Cargando…
The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers
PURPOSE: Previously, Kawasaki disease (KD) treatment with low-dose aspirin was administered for 6–8 weeks after the acute phase. However, inflammatory marker levels normalize before 6–8 weeks. In this study, we aimed to investigate the clinical outcome of short-term low-dose aspirin treatment based...
Autores principales: | Yoo, Jae Won, Kim, Ji Mok, Kil, Hong Ryang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pediatric Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309321/ https://www.ncbi.nlm.nih.gov/pubmed/28203257 http://dx.doi.org/10.3345/kjp.2017.60.1.24 |
Ejemplares similares
-
Kawasaki Disease and Hyponatremia
por: Kil, Hong Ryang
Publicado: (2010) -
Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities
por: Kim, Hyun Jung, et al.
Publicado: (2016) -
Is High-Dose Aspirin Necessary in the Acute Phase of Kawasaki Disease?
por: Lee, Goni, et al.
Publicado: (2013) -
Effect of different doses of aspirin on the prognosis of Kawasaki disease
por: Wang, Jinxin, et al.
Publicado: (2020) -
Duration of High-Dose Aspirin Therapy does not Affect Long-Term Coronary Artery Outcomes in Kawasaki Disease
por: Migally, Karl, et al.
Publicado: (2018)